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Although the rathogenesis of psoriasis vulgaris is still un-
known, severa characteristics point to an immunologically 
mediated process. Epidermal psoriatic lesions are character-
ized by a hyperproliferation of keratinocytes and an infiltra-
tion ofT lymphocytes and granulocytes. Because the former 
may be mediated in part by Iymphokines secreted by T cells, 
we have focussed our interest on the in vivo and in vitro cyto-
kine secretion patterns of T lymphocytes from psoriatic le-
sions. In five patients T lymphocytes were obtained from 
epidermal specimens. The cells were propagated with lectin 
and irradiated feeder cells and subsequently cloned by limit-
ing dilution. The resulting T-cell clones were phenotypi-
cally and functionally characterized. Our data show that the 
majority ofT-cell clones were CD4+ (74%), whereas only 
25% were CDS+ and 1 % were CD4-/CDS-. Also, we have 
further investigated the cytokine secretion pattern of T-cell 
lines or CD4+ T-cell clones, respectively. All cells tested 
A lthough the pathogenesis of psoriasis vulgaris is not y. et clear, there are several features of the disease that suggest an immunologically mediated process me-diated by T cells infiltrating into the epidermis. The inflammatory infiltrations in psoriasis vulgaris are 
characterized by a hyperproliferation of keratinocytes, increased 
numbers of activated epidermal T lymphocytes, neutrophil granu-
locytes, and alterations of the epidermal vascular system. An activa-
tion ofkeratinocytes seems to playa major role in the disease, which 
in part is mediated by lymphokines secreted from T cells. It has been 
demonstrated that interferon (IFN)-y can lead to the expression of 
human leukocyte antigen (HLA) class II molecules, intercellular 
adhesion molecule (ICAM)-l, and gamma-IP-I0 in lesional kerati-
nocytes [1] . Furthermore, keratinocytes express high levels of trans-
forming growth factor (TGF)-a [2], interIeukin IL-8 [3 ,4], IL-6, 
and IL-l [5], of which TGF-a and IL-6 may act as autocrine growth 
factors [6], whereas IL-8 has been shown to be a chemoattractant for 
T lymphocytes and neutrophils [7] . TGF-a can be upregulated by 
IFN-y, tumor necrosis factor (TNF)-a, IL-la, IL-6, and IL-8 
[1,8,9]. Unfortunately, little is known about possible downregulat-
ing factors on keratinocytes. 
CD4+ T lymphocytes can modulate immunologic reactions by 
their ability to produce various immunoregulatory lymphokines 
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produced interferon-y whereas only a minority secreted in-
terleukin {IL)-4. Moreover, these cells produced high 
amounts ofIL-2 but only little or no IL-10 or tumor necrosis 
factor-a. To correlate these data with the in vivo situation, 
biopsies from psoriatic lesions of five patients were investi-
gated for the presence of the mRNA of IL-4, IL-10, and 
interferon-y using the polymerase chain reaction. In these 
biopsies only the mRNA for the Thl cytokine interferon-y 
but not for the Th2 cytokines IL-4 and IL-10 could be de-
tected. Identical experiments were performed to test the in 
vivo cytokine production of synovial fluid mononuclear cells 
of two patients with arthropathia psoriatica. Again, only the 
mRNA for interferon-y but not IL-4 could be detected. This 
indicates that T cells involved in psoriasis exhibit a Th 1-like 
cytokine secretion profile. Key words: cytokine production/epi-
dermal T cells. ] Invest Dermato11 02:145 -149, 1994 
such as IL-4, IL-I0, or IFN-y. It has been widely accepted that 
human helper T cells can be subdivided into different functional 
subsets according to their secreted lymphokine pattern. Helper T 
cells that produce IFN-y but no IL-4 are classified as Thl cells [10] , 
which are found to be involved in cellular immune reactions and are 
thought to mediate delayed-type hypersensitivity [11]. T cells spe-
cific for mycobacteria [12], Borrelia burgdorferi [13] , Yersina enterocoli-
tica [14], Yersillia pseudotuberculosis, Salmotlella, Morganella, E. coli, 
Klebsiella, Serratia, Shigella, Chlamydia (Schlaak et aI, submitted for 
publication), and nickel-ions [15] belong to the Th 1 subset. In con-
trast, T cells specific for allergens [16] or Toxocara canis [17] produce 
only little or no IFN-y but high amounts of IL-4 and belong to the 
Th2 subset. Th2 cells are associated with humoral immunity and 
increased IgE production. T cells that produce both IFN-y and IL-4 
like tetanus toxoid or Atlisakis reactive helper lymphocytes (Schlaak 
et ai, submitted for publication) are called ThO cells. Their func-
tional relevance remains to be elucidated. 
In the present study we have investigated the phenotype and the 
i" vitro and i" vivo cytokine production of epidermal T lymphocytes 
from psoriatic l~si~ns and arthropa~hia. psoriatica. Our results indi-
cate that the maJonty ofT cells reSIde III the CD4+ jCDS- popula-
tion and produce IFN-y and no or very little 11-4 and IL-I0. This 
shows that T cells involved in psoriasis vulgaris belong to the Th 1 
subset. 
MATERIALS AND METHODS 
Patients All patients gave informed consent to this work, conformant to 
the Declaration of Helsinki ethical guidelines. 
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Cells Epidermal bullae were induced on psoriati~ lesion: as described [18]. 
Epidermal specimens were resec~ed and washed .wlth ~tenle phosphate-buf-
fered saline (PBS). Then the specimens were cut Into pieces of2 X 2 mm and 
seeded into 96-well round-bottom microriter plates (Greiner, Nlirtingen, 
Germany) containing 200 JlI culture medium supplemented with 1 ng/ml 
recombinant human interleukin 2 (rhIL-2). After 24 h incubation, the out-
growing T lymphocytes were harvested, washed, and ~I?ned by limi.ting 
dilution in the presence of 1 Jlg/mI phytohemaggluttrun (PHA; Difco, 
Paisley, Scotland) and irradiated (4000 rad) allogeneic peripheral blood 
mononuclear cells (PBMCs). The resulting T-cell clones were phenotyped 
and propagated by weekly restimulation with mitogen and irradiated feeder 
cells in culrure medium containing 1 ng/mI rhIL-2. The Burkitt's lym-
phoma cell line Daudi was cultured in RPMI plus 5% fetal calf serum (FCS). 
All cells were cultivated at 37 DC and 5% CO2 in a humidified atmosphere. 
Reagents Recombinant human E. coli-derived IL-2 (kindly provided by 
Cetus Corp., Emeryville, CA) was used as highly purified protein. B-cell 
hybridomas producing anti-CD3, anti-CD4, and anti-CD8 mouse antibod-
ies were obtained from the American Type Culture Collection (ATCC, 
Rockville, MD). Culture medium for human cells was RPMI (Biochrom, 
Berlin, Germany) supplemented with 10% human AB serum, 2 ruM L-glu-
tamine (Sigma, St. Louis, MO), 50 Jlg/ml gentamycin (Gibco). Culture 
medium for the CTLL cells was Iscove's medium (Biochrom) supplemented 
with 10% FCS (Gibco), 2 ruM L-glutamine (Sigma), 50 Jlg/mI gentamycin, 
and 40 ng/ml rIL-2. 
Assays for Lymphokine Production These assays were performed in 
96-well flat-bottomed microtiter plates (Greiner, Nlirtingen, Germany) 7 d 
after the last restimulation. Mitogenic stimulation was performed by incu-
bating 5 X 10' T cells with 5Jlg/mI PHA and 5 X 10' irradiated (4000 rad) 
Daudi lymphoma cells in a volume of 200 Jll per well. Supernatants were 
harvested after 24 h (for IL-2 and IL-4) and 48 h (IFN-y, TNF-a, and IL-I0), 
respectively, stored immediately at - 20 DC, and thawed before testing. The 
amoung ofIL-2 and IL-I0 in the supernatants was determined by using the 
IL-2 -dependent murine CTLL-2 cell line [19] or the IL-I0-dependent 
murine mast cell line D36 (Schlaak et ai, submitted for publication). The 
amounts ofIL-4, TNF;a, and IFN-y in the culture supernatants were deter-
mined by using cytokine-specific enzyme-linked immunosorbent assays 
(ELlS As) as previously described [14] . All assays were performed in tripli-
cate. A standard curve was prepared in each assay. Detectable amounts of 
cytokines were not produced in the absence of stimulation. 
Detection of mRNA by Polymerase Chain Reaction (PCR) Punch 
biopsies from psoriatic skin or cell pellets containing 1 X 106 synovial fluid 
mononuclear cells were subjected to RNA extraction by the guanidium 
isothiocyanate/phenol-chloroform procedure [20]. The cDNA was synthe-
sized with moloney murine leukemia virus reverse transcriptase (Gibco) and 
oligo (dt) priming. PCR was carried out in a buffer containing 50 ruM KCI, 
10 ruM Tric-HCl (pH 8,3),1.5 ruM MgCI2' 100 Jlg/ml gelatin, 200 J.lM 
deoxynucleotide triphosphate (dNTP), 1.25 D/mI Taq DNA-polymerase 
(Boehringer Mannheim, Mannheim, Germany), and 20 pmol of the respec-
tive primers. The following primers were used: p-actin (661 base pairs [hpj): 
TGACGGGGTCACCC ACACTGTGCCCATCTA (sense), CTA-
GAAGCATfTGCGGTGGACGATGGAGGG (antisense); IFN-y (494 
bp): ATGAAATATACAAGTTATATCTTGGCTTT (sense), GAT-
GCTCTTCGACCTCGAAACAGCAT (antisense); IL-4 (456 bp): 
ATGGGTCTCACCT CCCAACTGCT (sense), GAACACTfTGAA-
TATTTCTCT CTCAT (antisense); IL-I0 (352 bp): CTGAGAACCAA-
GACCCAGACATCAAGGC (sense), GACCCAGCCCCTTGAGAA 
ACCTT A TTG (antisense). The reaction consisted of 35 cycles of denatura-
tion at 94 DC for 30 sec, annealing at 55 DC for 40 sec, and extension at 72 DC 
for 1 min (annealing time for the first three cycles: 58 DC). PCR products 
were analyzed by electrophoresis on 1.5% agarose gels and visualized by 
ethidium bromide staining. 
RESULTS 
Patients Epidermal specimens were obtained from 10 patients 
who were hospitalized with psoriasis vulgaris. They were not 
treated until the biopsies were taken. Patient A was an 80-year-old 
woman, patient B a 37-year-old woman, patient C a 65-year-old 
woman, patient D a 27-year-old man, patient E a 35-year-old man, 
patient 1 a 53-year-old woman, patien.t 11 a 33-year-old man, patient 
III an 83-year-old woman, patient IV a 31-year-old man, patient V a 
34-year-old man, patient VI a 46-year-old man, and patient VII a 
59-year-old man. 
CD4/CD8 Phenotypes of Epidermal T Lymphocytes from 
Psoriatic Lesions A total of 163 T-cell clones were obtained 
from patients A, B, C, D, and E. All clones were CD3+. Of these, 
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Table I. CD4/CD8 Phenotype ofT Lymphocytes from 
Epidermal Psoriatic Lesions" 
Number of C lones CD4+ /CD8- CD4-/CD8+ CD4-/CDS-
Patient (n) (%) (%) (%) 
A 8 50 50 0 
B 46 78 22 0 
C 45 73 24 3 
D 46 83 17 0 
E 18 55 39 6 
Total 163 74 25 1 
• Lesional T cells were isolared from epidermal specimens of five patients with aCUte 
psoriasis vulgaris and cloned by limiting dilution in the presence of 1 J.Lg/m1 phytohe_ 
magglutinin and irradiated allogeneic feeder cells. The resulting T-cell clones were 
phenotyped using a beta-galactosidase-linked single-cell immunoassay. 
120 (74%) were CD4+/CD8- and 41 (25%) were CD4-jCD8+. 
Two T-cell clones (1 %) were CD4-/CD8+. All data are summa_ 
rized in Table I. 
IL-2, IL-4, IL-I0, TNF-a, and IFN-YProduction ofCD4- and 
CDS-Positive Epidermal T Lymphocytes from Psoriatic Le. 
sions In Vit,.o We have randomly chosen 76 CD4+ T-cell clones 
from patients C, D, and E, as well as 10 CD8+ clones from patient C 
and assessed them for the production ofIL-2, 11-4, and IFN-y after 
stimulation with lectin and irradiated allogeneic PBMCs. Our re-
sults show that all clones produce large amounts ofIL-2 and IFN-y, 
whereas only little or no IL-4 is found . Of the 10 CD8+ clones 
tested only one produced IL-4 whereas all secreted IFN-y after 
mitogenic stimulation. Four of 29 CD4+ clones of patient C pro_ 
duced IL-4 and IFN-y, resulting in a ThO lymphokine secretion 
pattern, whereas 25 clones secreted IL-2 and IFN-y but no IL-4, 
resulting in a Thl pattern (Table II). In patient D, 18 clones showed 
a classical Thl pattern, nine clones produced only very little IL-4 
(less than 150 pg/ml) but high amounts of IFN-y, and 10 clones 
produced more than 150 pg/ml IL-4 and IFN-y, resulting in a ThO 
pattern (Table II). In patient E, eight of 10 clones tested produced no 
IL-4 but IFN-y, whereas two clones secreted IFN-y and less than 
150 pg/ml IL-4 (Table II). On average the clones in patient C 
produced about 19.6 times more IFN-y than IL-4, whereas this ratio 
was 18.4 for patient D and 45.3 for patient E (Table II) . The data for 
production ofIL-4 and IFN -I' by individual T-cell clones of patients 
C, D, and E are shown in Fig 7. Our cloning procedure does not 
promote the outgrowth ofTh 1 cells, as we have isolated T cells that 
produce large amounts of IL-4 under identical conditions [22] . In 
addition, all clones from patients D and E were tested for the pro-
duction of IL-l 0 and TNF-a after stimulation with lectin and irra. 
diated accessory cells. As shown in Table II, these cytokines are not 
at all or only in very small amounts produced by the T-cell clones 
tested. Under identical conditions ThO cells (i.e., Anisakis or Tetanus 
toxoid reactive T cells) produce much higher amounts of both IL_ 
10 (approximately 4000 pg/ml) and TNF-a (approximately 2000 
pg/ml) (Schlaak et ai, submitted for publication) . 
In Vivo Cytokine Production by T Cells from Biopsies of 
Psoriatic Lesions To correlate the in vitro data with the in vivo 
situation we have investigated punch biopsies of psoriatic lesions of 
five patients (patients III to VII) for the mRNA ofIL-4, IL-I0, and 
IFN-y. Directly after isolation the tissue samples were stored in 
liquid nitrogen and RNA extraction was performed immediately 
after thawing. As shown in Fig 2, only the mRNA for IFN-y, but 
not for IL-4, was detectable. The mRNA for IL-I0 was not ex-
pressed in these samples (data not shown). 
Cytokine Production by Synovial Fluid Mononuclear Cells 
(SFMCs) from Patients with Arthropatbia Psoriatic a Be-
cause psoriasis is sometimes associated with arthritis we have exam-
ined the in vivo cytokine production by isolating synovial fluid 
mononuclear cells from two patients (patients I and II) with arthro-
pathia psoriatica. Our results show that the mRNA for IFN-y is 
expressed in the SFMCs, whereas the mRNA for IL-4 and IL-I0 is 
not detectable (Fig 3). This indicates that not only epidermal but 
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Table II. IFN-y, IL-2, IL-4, IL-I0, and TNF-a production by T-cell Clones or Lines' from Epidermal Psoriatic Lesionsb 
IFN-y IL-2 IL-4 IL-I0 TNF-a IFN-y/IL4 
Patient (pg/m1) (pg/m1) (pg/ml) (pg/m1) (pg/ml) 
A' 5130 n.d. 800 n.d. n.d. 6,4: 1 
B' 6453 n.d. 100 n.d. n.d. 64.5: 1 
C' 1312 ± 105 11979 ± 780 67 ± 14 n.d. n.d. 19.6 : 1 
0 8333 ± 415 4286 ± 153 452 ± 32 75 ± 12 196 ± 5 18.4: 1 
E 1133 ± 99 4522 ± 134 25 ± 5 90± 9 72 ± 15 45.3: 1 
• The data for patients A and B are obtained from a representative experiment performed with cell lines . 
• 5 X 10' T cells were stimulated with 5 PS/m1 PHA and 5 X 10' DaudiB lymphoma cells in a volume of200 pI. Supernatants were harvested after 24 h (for IL-2 and IL-4) and 48 h 
(for IFN-y). There were no cytokines detectable in the absence of stimulation. The amount ofIL-4 and IFN-ywas determined by specific ELiSAs. The data forpanents C, D, andE are 
expressed as mean values ± SEM. . . . . . . 
, For patient C clone 39 that exhIbIted a Th2-hke profile (360 PS/m1IFN-y and 8000 ps/mIIL-4) was excluded from the stauStlcal analySIS. 
also synovial T cells involved.in ~soriatic disease bel~ng to the same 
functional subset, as both resIde m the Thl population. 
DISCUSSION 
In this paper we present data on the in vitro and in vivo cytokine 
production of e~idermallesional T cells and SFM~s o[ patients .with 
psoriasis vulgans. Our results show that the maJonty of leslOnai 
epidermal T cells pheno.typically reside i.n the CD4+ populat.ion, 
which is in agreement wIth prevIOUS studIes [23,24], and function-
ally belong to the Th 1 subset with production ofIFN-y and IL-2 but 
no or very little IL-4, IL-lO, and TNF-a. Identical results could be 
obtained from SFMCs of two patients with acute arthropathia psor-
iatica. 
Psoriasis vulgaris is a hyperkeratotic skin disease associated with 
genetic and environmental triggering factors [25]' Because the his-
tomorphologic picture is characterized by proliferating keratino-
cytes and immunocytes such as dendritic cells, macrophages, and 
epidermal T cells, an immunologically mediated process is thought 
to playa pathogenetic role. Nevertheless only little is known about 
the underlying factors leading to exacerbation and perpetuation of 
psoriasis. Still, there is evi~ence that f~rther ~xamin~tion of the role 
ofkeratinocytes and cytokme production by mfiltratmg T cells may 
contribute to an understanding of this disease. It has been shown 
that patients benefit from treatment with cyclosporine A, a drug 
known to selectively suppress proliferation and cytokine production 
by T cells [26]. In a recent stl1dy a positive effect of a treatment with 
an anti-CD4 antibody was described, indicating a major role for 
CD4+ helper lymphocytes [22]. Furthermore, the T-cell product 
IFN-y, when injected into lepromatous or keloid lesions from non-
psoriatic patients, can lead to a psoriasiform epidermal reaction 
[27,28] . Whereas IL-2 therapy may be followed by exacerbation of 
psoriatic lesions [29], TNF-a even has beneficial effects [30]. These 
data show that cytokines secreted by T cells may be important 
mediators of the disease in vivo. Furthermore, there is evidence from 
in vitro srudies that IFN-y can lead to an upregulation of the adhe-
sion molecule ICAM-l, as well as the TGF epidermal growth factor 
(EGF) receptor and major histocompatibility complex class II mole-
cules on and cytokine production (r-IP-lO, TGF-a) by keratino-
cytes [1,9]. Several studies were performed to study the distribution 
and production of cytokines in epidermal psoriatic lesions. It has 
been demonstrated by PCR that the mRNA for IFN-y but not 
TNF-a is expressed in psoriatic lesions but not in normal skin [31]. 
In aqueous extracts of the strateum corneum from psoriatic lesions, 
IFN-y, IFN-a, and TNF-a and -p, but not IL-2, IL-4, and IL-6, 
could be detected [32]. 
From these data it may be concluded that cytokine production by 
T cells is essential for the outcome of psoriasis by activating kerati-
nocytes. Furthermore, IFN-y may be the crucial T-cell-derived 
lymphokine in the interaction between the keratinocyte and T cell. 
Although quite a few studies were undertaken to examine activating 
factors in the pathogenesis of psoriasis, little interest has been fo-
cused on immunoregulatory or "suppressive" mediators. 
There is increasing evidence that immune reactions can be regu-
lated by CD4+ T cells and their secreted products. Mosmann et af 
patient C patient D patient E 
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Figure 1. (a-c) IFN-y and IL-4 production by epidermal T helper cell clones from patients C, D, and E. 5 X 10· T cells were stimulated with phytohemag-
glutinin (1 Itg/ml) and 5 X 10' irradiated Daudi B lymphoma cells. Supernatants were harvested after 24 h (IL-4) and 48 h (IFN-y) and tested for IL-4 and 
IFN-y as described. 
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Figure 2. In lIivo cytokine production by T. cells from. epidermal pso~iatic 
lesions. Punch biopsies were taken from epidermal lesIOns of five pat~ents 
with psoriasis vulgaris. Total mRNA was extracted and reverse transcnbed. 
PCR was performed with primers specific for actin (not shown), IL-l0 (not 
shown), IL-4, and IFN-y. A full-length IL-4 eDNA was used as positive 
control. 
1
10] have classified murine helper lymphocytes according to their 
ymphokine secretion patterns. Only recently we and others have 
shown that human helper lymphocytes can also be subdivided into 
functionally different subsets. T cells reactive with various bacteria 
[12-14,17] or contact allergens like nickel [15] produce IFN-y but 
no IL-4 and thus belong to the Th 1 subset. T cells reactive with 
tetanus toxoid or Allisakis produce both IFN-y and IL-4 and are 
classified as ThO cells, whereas T cells from atopic dermatitis that 
are reactive with allergens and secrete IL-4 but no IFN-y reside in 
the Th2 population [16]. Additionally, it has been demonstrated in 
the mouse system that Th 1 cells secrete IL-2 and no IL-l 0 whereas 
the opposite is true for Th2 cells. Th 1 cells are thought to give 
"help" for cellular immune reactions [33], whereas humoral mech-
anisms are "suppressed" [34]. On the other hand Th2 cells can 
downregulate cellular reactions like intracellular kill [14,35] and 
monokine production [34] and cytokine production by Thl cells 
[37] and give "help" for B-cell functions via cytokines, such as IL-4 
and IL-I0 [38,39]. 
Our studies show that CD4+ T cells involved in psoriasis exhibit a 
restricted cytokine profile with production of the pro inflammatory 
lymphokines IFN-y and IL-2: In contrast, the antiinflammatory 
cytokines IL-4 and IL-I0, wluch are known to do~nr~gulate t~e 
production and effects of~FN-'y, cannot be detected JI1 VIVO. In addi-
tion to the data presented m thiS work, we have been able to demon-
strate by PCR that activated human keratinocytes can produce the 
mRNA for the "Thl-" and IFN-y-inducing factor IL-12. In con-
trast, only very little IL-l 0 mRN A and no IL-l 0 protein was detect-
able in activated keratinocytes (Schlaak et ai, manuscript in prepara-
tion). This may point to a preferential activation and induction of 
Thl cells by keratinocytes. By lacking IFN-y-downregulating fac-
tors (IL-4, IL-I0) and expressing IFN-y-inducing factors (IL~2, 
IL-12) epidermal T cells and keratinocytes may not be able to 111-
terrupt the self-perpetuat~nl? hyperk~ratotic process involved in 
psoriasis. Therefore, psonasls vulgans may: be an ex~mple of an 
immunodysregulatory process. Although epldermalleslOnal T cells 
from patients with psoriasis and T cells specific for bacterial anti-
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
IL-4 IFN-l 
C C 
0 c 0 0 ....... ....... ....... ....... () C C () C C () Q) Q) Q) Q) 
0> en ~ 1lj O>~ ....... 0 ct:S Q) ct:S ct:S Q) 
C 0.. 0.. 0.. c 0.. 0.. 
Figure 3. In vivo cytokine production by SFMCs from patients with arthro_ 
pathia psoriatica. Total mRNA was extracted from 1 X 10· SFMCs of two 
patients with arthropathia psoriatica and reverse transcribed. PCR was per-
formed as described in Fig 2. 
gens exhibit the same cytokine pro~le, it can not b~ conclu~e~ f~orn 
these experiments that the underlymg pathogeneSIs of psonasls IS of 
bacterial origin [40]. Still, it is known that bacterial infections may 
lead to an exacerbation of the disease. This can in part be explained 
by the finding that T cells reactive with bacteria produce high 
amounts ofIFN-y but no IL-4 and IL-I0, resulting in a Thl cyto-
kine profile. Thus, conditions that le~d to Th 1 b~t not :rhO or Th.2 
cytokine production could be responsible for the mduc~lOn of PSOri-
atic lesions. In fact, contact allergens that are known to 1I1duce a Th 1 
response by epidermal T cells can promote the disease whereas 
atopic dermat!tis that is associated wi~~ a Th2 cytokine p.rofile does 
not induce thiS phenomenon. In additIOn, the therapeutic effect of 
ultraviolet-irradiation may be mediated by an induction ofTh2 cells 
by Langerhans cells [41 J, which may suppress IFN-y production by 
secreting IL-4 and IL-I0. 
In summary, our data show that the T cells involved in psoriasis 
vulgaris are CD4+ cells that functionally exhibit a Thl phenotype 
with production of IFN-y and IL-2 but no or very little IL-4 and 
IL-I0 both in vivo and in vitro. These data may point to an immuno-
dysregulatory process involved in psoriasis vulgaris. 
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